Report / Paper metadata
Clinical features and management of GPRC5D-associated adverse events in novel GPRC5D × CD3 bispecific talquetamab-treated relapsed/refractory multiple myeloma patients: the MonumenTAL-1 China cohort experience.
A biomedical paper record. This page preserves its title, publication metadata and identifier, not the full article. The title alone does not establish the study findings or their clinical importance.
- Journal
- Hematology (Amsterdam, Netherlands)
- Kind
- Paper metadata
- Identifier
- PMID 42679119